Multicomponent pharmaceutical cocrystals: furosemide and pentoxifylline

The combination of the active pharmaceutical ingredients furosemide [4‐chloro‐2‐(furan‐2‐ylmethylamino)‐5‐sulfamoylbenzoic acid] and pentoxifylline [3,7‐dimethyl‐1‐(5‐oxohexyl)‐3,7‐dihydro‐1H‐purine‐2,6‐dione] produces a 1:1 cocrystal, C₁₂H₁₁ClN₂O₅S·C₁₃H₁₈N₄O₃, (I), a 1:1 cocrystal hydrate, C₁₂H₁₁ClN₂O₅S·C₁₃H₁₈N₄O₃·H₂O, (II), and a 1:1 cocrystal acetone solvate, C₁₂H₁₁ClN₂O₅S·C₁₃H₁₈N₄O₃·C₂H₆O, (III). These structures exhibit the presence of a rarely encountered synthon with the graph set R₂²(7). All potential hydrogen‐bond donors of furosemide participate in hydrogen‐bond formation in (I)–(III). However, only two hydrogen‐bond acceptors of furosemide are active in (I) and (II), and only one is active in (III). Four hydrogen‐bond acceptors of pentoxifylline are active in (II), three in (I) and two in (III). These observations are in good agreement with the calculated packing indexes of 69.5, 69.6 and 68.8% for (II), (I) and (III), respectively.     

Die Struktur des Antibioticums Roridin H. Verrucarine und Roridine, 20. Mitt. [1]

Structure 1 has been established for roridin H (C₂₉H₃₆O₈), an antibiotic isolated from Myrothecium verrucaria and formerly namend verrucarin H [3]. Base catalysed hydrolysis of 1 gave the known terpene alcohol verrucarol ( 8 ; C₁₅H₂₂O₄) and myrothecinic acid ( 3 ; C₁₄H₁₈O₆), a previously undescribed dicarboxylic acid. The structure of 3 was determined by spectral methods and by chemical cleavage of the unusual acetal group of dimethyl hexahydromyrothecinoate ( 6 ) by hydrolysis with HCl in the presence of 2, 4-dinitrophenylhydrazine, producing the 2, 4-dinitrophenylhydrazone 13 of 3-methylglutaric acid semialdehyde 10 and methyl 6, 7-dihydroxy-octanoate ( 11 ). 13 was transformed in to dimethyl 3-methylglutarate ( 15 ). Cleavage of 11 with HIO₄ gave acetaldehyde and adipic acid semialdehyde ( 17 ) which was oxidized to adipic acid ( 19 ). The 220 MHz NMR spectra of roridin H ( 1 ) and dimethyl hexahydromyrothecinoate ( 6 ) allowed unequivocal assignment of the signals to the majority of the protons in the antibiotic.     

(4′-Chloro-2,2′:6′,2′′-terpyridine-N,N′,N′′)(diethylphosphinothioato-S)platinum(II) tetraphenylborate

The title compound, [Pt(C₄H₁₀O₃PS)(C₁₅H₁₀ClN₃)](C₂₄H₂₀B), has a distorted square-planar coordination geometry at the platinum(II) centre, due to the constraints of the tridentate ter­pyridine ligand. The Pt^II-bound diethyl­phosphino­thio­ate ligand takes up a conformation to avoid non-bonding contacts with atoms H6 and H6′′.     

Die Konstitution von Roridin D. Verrucarine und Roridine, 12. Mitteilung

The antibiotic roridin D (C₂₉H₃₈O₉), a companion of roridin A, yields on base catalysed hydrolysis verrucarol ( 3 ) and the hitherto unknown 2, 3-epoxy-2-anhydrororidinic acid ( 4 ) (C₁₄H₁₈O₇). Roridin D is a macrocyclic diester to which structure 1 is assigned. In roridin D an epoxy group replaces the hydroxyl group of roridin A.     

Structure of the antibiotic Roridin E

Structure 1 has been established for roridin E (C₂₉H₃₈O₈), an antibiotic isolated from cultures of Myrothecium species. Base catalysed hydrolysis of 1 gave the known sesquiterpene alcohol verrucarol ( 4 ; C₁₅H₂₂O₄) and 2′-anhydrororidinic acid ( 6 ; C₁₄H₂₀O₆), a new dicarboxylic acid. The structure of 6 was determined by spectral analysis of its dimethyl ester 7 , dimethyl hexahydro-2′-anhydrororidinate ( 9 ), the acetyl derivative 10 , and the oxidation product 11 .     

5‐(2‐Chloro­phenyl­diazenyl)­salicyl­aldehyde and 4‐(2‐chloro­phenyl­diazenyl)‐2‐{[tris­(hydroxy­methyl)­methyl]­amino­methyl­ene}cyclo­hexa‐3,5‐dien‐1(2H)‐one

The mol­ecule of the former title compound, C₁₃H₉ClN₂O₂, (I), is nearly planar, with an intramolecular O⋯O hydrogen bond of 2.692 (2) Å. The latter title compound, C₁₇H₁₈ClN₃O₄, (II), exists in the keto–amine tautomeric form, with a strong intramolecular hydrogen bond of 2.640 (2) Å between the O and N atoms, the H atom being bonded to the N atom. The azo­benzene moieties of both mol­ecules have trans configurations, and the dihedral angle between the planes of the two aromatic rings is 4.1 (1)° in (I) and 9.9 (1)° in (II). The N—H⋯O hydrogen‐bonded rings are almost planar and coupled with the cyclo­hexa­diene rings in (II).     

Synthesis,molecular weights and infrared spectra of some scandium(III) higher carboxylates

Summary Anhydrous scandium(III)carboxylates of general composition SC(O₂CR)₃ (where R = C₁₁ H₂₃, C₁₃ H₂₇, C₁₅H₁₃, C₁₇H₃₅ and C₂₁ H₄₃) have been synthesized in aqueous solution. Hexacoordinated monomers are suggested on the basis of elemental analyses, molecular weights and i.r. spectra of the complexes.     

Stoffwechselprodukte von Mikroorganismen. 253. Mitteilung. Hormaomycin,ein neues Peptid-lacton mit morphogener Aktivität auf Streptomyceten

Hormaomycin, a Novel Peptide Lactone with Morphogenetic Activity on Streptomyces A culture identified as Streptomyces griseoflavus (strain W-384) has been found to produce a novel peptide-lactone antibiotic designated hormaomycin ( 6 ). The empirical molecular formula of the compound is established to be C₅₅H₆₉ClN₁₀O₁₄. The constituent amino acids of the antibiotic are suggested to be allothreonine ( 1 ; 1), isoleucine ( 2 ; 1), 3-methyl-phenylalanine ( 3 ; 2), and, for the first time identified from a natural source, 4-[(Z)-prop-1-enyl]-proline ( 4 ; 1) and 3-(2-nitrocyclopropyl)-alanine ( 5 ; 2). The amino acids were delivered by acidic hydrolysis and assigned by high-resolution- GC/MS analysis (after transformation to derivatives) in combination with extended 2D-NMR experiments of the antibiotic itself. From the latter, it became plausible that the N-terminus of the peptide chain is acylated by a Cl-containing derivative of 1H-pyrrol-2-carboxylic acid. Hormaomycin is active against some Gram-positive bacteria. In addition, the antibiotic exhibits potent aerial mycelium-inducing activity and effects the production of antibiotics.     

6‐Chloroisocytosine and 5‐bromo‐6‐methylisocytosine: again,one or two tautomers present in the same crystal?

It is well known that pyrimidin‐4‐one derivatives are able to adopt either the 1H‐ or the 3H‐tautomeric form in (co)crystals, depending on the coformer. As part of ongoing research to investigate the preferred hydrogen‐bonding patterns of active pharmaceutical ingredients and their model systems, 2‐amino‐6‐chloropyrimidin‐4‐one and 2‐amino‐5‐bromo‐6‐methylpyrimidin‐4‐one have been cocrystallized with several coformers and with each other. Since Cl and Br atoms both have versatile possibilities to interact with the coformers, such as via hydrogen or halogen bonds, their behaviour within the crystal packing was also of interest. The experiments yielded five crystal structures, namely 2‐aminopyridin‐1‐ium 2‐amino‐6‐chloro‐4‐oxo‐4H‐pyrimidin‐3‐ide–2‐amino‐6‐chloropyrimidin‐4(3H)‐one (1/3), C₅H₇N₂⁺·C₄H₃ClN₃O⁻·3C₄H₄ClN₃O, (Ia), 2‐aminopyridin‐1‐ium 2‐amino‐6‐chloro‐4‐oxo‐4H‐pyrimidin‐3‐ide–2‐amino‐6‐chloropyrimidin‐4(3H)‐one–2‐aminopyridine (2/10/1), 2C₅H₇N₂⁺·2C₄H₃ClN₃O⁻·10C₄H₄ClN₃O·C₅H₆N₂, (Ib), the solvent‐free cocrystal 2‐amino‐5‐bromo‐6‐methylpyrimidin‐4(3H)‐one–2‐amino‐5‐bromo‐6‐methylpyrimidin‐4(1H)‐one (1/1), C₅H₆BrN₃O·C₅H₆BrN₃O, (II), the solvate 2‐amino‐5‐bromo‐6‐methylpyrimidin‐4(3H)‐one–2‐amino‐5‐bromo‐6‐methylpyrimidin‐4(1H)‐one–N‐methylpyrrolidin‐2‐one (1/1/1), C₅H₆BrN₃O·C₅H₆BrN₃O·C₅H₉NO, (III), and the partial cocrystal 2‐amino‐5‐bromo‐6‐methylpyrimidin‐4(3H)‐one–2‐amino‐5‐bromo‐6‐methylpyrimidin‐4(1H)‐one–2‐amino‐6‐chloropyrimidin‐4(3H)‐one (0.635/1/0.365), C₅H₆BrN₃O·C₅H₆BrN₃O·C₄H₄ClN₃O, (IV). All five structures show R₂²(8) hydrogen‐bond‐based patterns, either by synthon 2 or by synthon 3, which are related to the Watson–Crick base pairs.     

Hydrogen‐bonded assembly in six closely related pyrazolo[3,4‐b]pyridine derivatives; a simple chain,three types of chains of rings and a complex sheet structure

Six closely related pyrazolo[3,4‐b]pyridine derivatives, namely 6‐chloro‐3‐methyl‐1,4‐diphenylpyrazolo[3,4‐b]pyridine‐5‐carbaldehyde, C₂₀H₁₄ClN₃O, (I), 6‐chloro‐3‐methyl‐4‐(4‐methylphenyl)‐1‐phenylpyrazolo[3,4‐b]pyridine‐5‐carbaldehyde, C₂₁H₁₆ClN₃O, (II), 6‐chloro‐4‐(4‐chlorophenyl)‐3‐methyl‐1‐phenylpyrazolo[3,4‐b]pyridine‐5‐carbaldehyde, C₂₀H₁₃Cl₂N₃O, (III), 4‐(4‐bromophenyl)‐6‐chloro‐3‐methyl‐1‐phenylpyrazolo[3,4‐b]pyridine‐5‐carbaldehyde, C₂₀H₁₃BrClN₃O, (IV), 6‐chloro‐4‐(4‐methoxyphenyl)‐3‐methyl‐1‐phenylpyrazolo[3,4‐b]pyridine‐5‐carbaldehyde, C₂₁H₁₆ClN₃O₂, (V), and 6‐chloro‐3‐methyl‐4‐(4‐nitrophenyl)‐1‐phenylpyrazolo[3,4‐b]pyridine‐5‐carbaldehyde, C₂₀H₁₃ClN₄O₃, (VI), which differ only in the identity of a single small substituent on one of the aryl rings, crystallize in four different space groups spanning three crystal systems. The molecules of (I) are linked into a chain of rings by a combination of C—H...N and C—H...π(arene) hydrogen bonds; those of (II), (IV) and (V), which all crystallize in the space group P, are each linked by two independent C—H...O hydrogen bonds to form chains of edge‐fused rings running in different directions through the three unit cells; the molecules of (III) are linked into complex sheets by a combination of two C—H...O hydrogen bonds and one C—H...π(arene) hydrogen bond; finally, the molecules of (VI) are linked by a single C—H...O hydrogen bond to form a simple chain.     

Synthesis and biological evaluation of novel indoleamide derivatives as antioxidative and antitumor agents

Novel indole amide derivatives C1-C10 were successfully synthesized and characterized by ¹H NMR, ¹³C NMR, IR, MS, and elemental analysis, and their molecular formulas were C₁₄H₁₀N₆O, C₁₃H₁₀N₄O, C₁₆H₁₃N₃O₂, C₁₉H₁₄N₂O₂, C₁₆H₁₁N₃OS, C₁₅H₁₃N₃O, C₁₂H₉N₅O, C₁₆H₁₀ClN₃OS, C₁₅H₁₇N₃O₂, and C₁₃H₁₄N₂O₃, respectively. The primary biological activities of these compounds were evaluated in vitro by the DPPH assay, H₂O₂-induced oxidative stress injury assay, and cytotoxicity assay. The results indicated that compounds C1, C2, C4, C7, and C9 exhibited DPPH·scavenging ability, while C3, C4, C5, and C8 showed potent growth-inhibitory activities against various human tumor cells, including MDA-MB-231, Hela, A549, and HT29. Interestingly, compound C4 showed potent scavenging effects on the DPPH radical and possessed protective effect on H₂O₂-induced oxidative stress injury in human neuroblastoma SH-SY5Y cells at low concentrations; however, C4 exhibited significant toxicity against four human tumor cells at a higher concentration in all treatments, and the range of IC₅₀ value was 7.91 to 13.35 μM.     

Structural basis of solid solution formation during chiral resolution

A systematic study of crystal packing in a series of structures is presented: an isostructural triplet of an optically active compound {(R)-2-(6,7-diethoxy-1,2,3,4-tetrahydro-1-isoquinolidene)-2-[2-hydroxy-3-(4-morpholinyl)propyl]mercaptoacetonitrile hydrochloride, C₂₂H₃₂ClN₃O₄S} 1, its racemate 2 and their achiral dehydroxy parent compound {2-(6,7-diethoxy-1,2,3,4-tetrahydro-1-isoquinolidene)-2-[3-(4-morpholinyl)propyl]mercaptoacetonitrile hydrochloride, C₂₂H₃₂ClN₃O₃S} 3. Based on the structures we suggest some requirements necessary for an optically active compound and its racemate to be isostructural. A generally used resolving agent d-champhor sulphonic acid was unable to provide full separation of the racemate. The crystal structure of a partially resolved product (C₃₂H₄₇N₃O₈S₂) 4 sheds light on the possible reasons of this failure. We suggest a few criteria for solid solution formation of diastereomeric salts.     

Hydrogen‐bonded sheet structures in methyl 4‐(4‐chloroanilino)‐3‐nitrobenzoate and methyl 1‐benzyl‐2‐(4‐chlorophenyl)‐1H‐benzimidazole‐5‐carboxylate

In methyl 4‐(4‐chloroanilino)‐3‐nitrobenzoate, C₁₄H₁₁ClN₂O₄, (I), there is an intramolecular N—H...O hydrogen bond and the intramolecular distances provide evidence for electronic polarization of the o‐quinonoid type. The molecules are linked into sheets built from N—H...O, C—H...O and C—H...π(arene) hydrogen bonds, together with an aromatic π–π stacking interaction. The molecules of methyl 1‐benzyl‐2‐(4‐chlorophenyl)‐1H‐benzimidazole‐5‐carboxylate, C₂₂H₁₇ClN₂O₂, (II), are also linked into sheets, this time by a combination of C—H...π(arene) hydrogen bonds and aromatic π–π stacking interactions.     

catena‐Poly[[[2‐(2‐chlorophenoxy)‐N′‐(2‐oxidobenzylidene‐κO)acetohydrazidato‐κ2N′,O]copper(II)]‐μ‐morpholine‐κ2N:O]

In the title compound, {[Cu(C₁₅H₁₁ClN₂O₃)(C₄H₉NO)]_n, the Cu^II cation has square‐pyramidal geometry. The morpholine ligand serves as a bridge to link two symmetry‐related metal atoms, resulting in an infinite chain structure along the a axis. Adjacent chains are extended into a two‐dimensional layered structure via hydrogen bonds formed between morpholine and amide N atoms [N—H...N = 2.971 (3) Å].     

From α‐carbamoyl‐α‐cyano­oxiranes to 3‐halogenopyruv­amides

The crystal structures of the first stable α‐diol from the α‐halogenopyruv­amide series, 3‐chloro‐2,2‐di­hydroxy‐3‐phenyl­propan­amide, C₉H₁₀­ClNO₃, and three products [3‐(4‐chloro­phenyl)‐2‐cyano‐2,3‐epoxy­propan­amide, C₁₀H₇­ClN₂O₂, 3‐bromo‐2‐cyano‐2‐hydroxy‐3‐p‐tolyl­propan­amide, C₁₁H₁₁Br­N₂O₂, 3‐bromo‐2‐oxo‐3‐p‐tolyl­propan­amide, C₁₀H₁₀­BrNO₂] obtained during the systematic synthesis of α‐halogenopyruv­amides are reported. The crystal structures are dominated by hydrogen bonds involving an amide group. The stability of the geminal diol could be ascribed to hydrogen bonds which involve both hydroxyl groups.     

Structural consequences of weak interactions in dispirooxindole derivatives

Spiro scaffolds are being increasingly utilized in drug discovery due to their inherent three‐dimensionality and structural variations, resulting in new synthetic routes to introduce spiro building blocks into more pharmaceutically active molecules. Multicomponent cascade reactions, involving the in situ generation of carbonyl ylides from α‐diazocarbonyl compounds and aldehydes, and 1,3‐dipolar cycloadditon with 3‐arylideneoxindoles gave a novel class of dispirooxindole derivatives, namely 1,1′′‐dibenzyl‐5′‐(4‐chlorophenyl)‐4′‐phenyl‐4′,5′‐dihydrodispiro[indoline‐3,2′‐furan‐3′,3′′‐indoline]‐2,2′′‐dione, C₄₄H₃₃ClN₂O₃, (I), 1′′‐acetyl‐1‐benzyl‐5′‐(4‐chlorophenyl)‐4′‐phenyl‐4′,5′‐dihydrodispiro[indoline‐3,2′‐furan‐3′,3′′‐indoline]‐2,2′′‐dione, C₃₉H₂₉ClN₂O₄, (II), 1′′‐acetyl‐1‐benzyl‐4′,5′‐diphenyl‐4′,5′‐dihydrodispiro[indoline‐3,2′‐furan‐3′,3′′‐indoline]‐2,2′′‐dione, C₃₉H₃₀N₂O₄, (III), and 1′′‐acetyl‐1‐benzyl‐4′,5′‐diphenyl‐4′,5′‐dihydrodispiro[indoline‐3,2′‐furan‐3′,3′′‐indoline]‐2,2′′‐dione acetonitrile hemisolvate, C₃₉H₃₀N₂O₄·0.5C₂H₃N, (IV). All four compounds exist as racemic mixtures of the SSSR and RRRS stereoisomers. In these structures, the two H atoms of the dihydrofuran ring and the two substituted oxindole rings are in a trans orientation, facilitating intramolecular C—H...O and π–π interactions. These weak interactions play a prominent role in the structural stability and aid the highly regio‐ and diastereoselective synthesis. In each of the four structures, the molecular assembly in the crystal is also governed by weak noncovalent interactions. Compound (IV) is the solvated analogue of (III) and the two compounds show similar structural features.     

Conversion of substituted 5‐aryloxypyrazolecarbaldehydes into reduced 3,4′‐bipyrazoles: synthesis and characterization,and the structures of four precursors and two products,and their supramolecular assembly in zero,one and two dimensions

The reaction of 5‐chloro‐3‐methyl‐1‐phenyl‐1H‐pyrazole‐4‐carbaldehyde with phenols under basic conditions yields the corresponding 5‐aryloxy derivatives; the subsequent reaction of these carbaldehydes with substituted acetophenones yields the corresponding chalcones, which in turn undergo cyclocondensation reactions with hydrazine in the presence of acetic acid to form N‐acetylated reduced bipyrazoles. Structures are reported for three 5‐aryloxycarbaldehydes and the 5‐piperidino analogue, and for two reduced bipyrazole products. 5‐(2‐Chlorophenoxy)‐3‐methyl‐1‐phenyl‐1H‐pyrazole‐4‐carbaldehyde, C₁₇H₁₃ClN₂O₂, (II), which crystallizes with Z′ = 2 in the space group P, exhibits orientational disorder of the carbaldehyde group in each of the two independent molecules. Each of 3‐methyl‐5‐(4‐nitrophenoxy)‐1‐phenyl‐1H‐pyrazole‐4‐carbaldehyde, C₁₇H₁₃N₃O₄, (IV), 3‐methyl‐5‐(naphthalen‐2‐yloxy)‐1‐phenyl‐1H‐pyrazole‐4‐carbaldehyde, C₂₁H₁₆N₂O₂, (V), and 3‐methyl‐1‐phenyl‐5‐(piperidin‐1‐yl)‐1H‐pyrazole‐4‐carbaldehyde, C₁₆H₁₉N₃O, (VI), (3RS)‐2‐acetyl‐5‐(4‐azidophenyl)‐5′‐(2‐chlorophenoxy)‐3′‐methyl‐1′‐phenyl‐3,4‐dihydro‐1′H,2H‐[3,4′‐bipyrazole] C₂₇H₂₂ClN₇O₂, (IX) and (3RS)‐2‐acetyl‐5‐(4‐azidophenyl)‐3′‐methyl‐5′‐(naphthalen‐2‐yloxy)‐1′‐phenyl‐3,4‐dihydro‐1′H,2H‐[3,4′‐bipyrazole] C₃₁H₂₅N₇O₂, (X), has Z′ = 1, and each is fully ordered. The new compounds have all been fully characterized by analysis, namely IR spectroscopy, ¹H and ¹³C NMR spectroscopy, and mass spectrometry. In each of (II), (V) and (IX), the molecules are linked into ribbons, generated respectively by combinations of C—H…N, C—H…π and C—Cl…π interactions in (II), C—H…O and C—H…π hydrogen bonds in (V), and C—H…N and C—H…O hydrogen bonds in (IX). The molecules of compounds (IV) and (IX) are both linked into sheets, by multiple C—H…O and C—H…π hydrogen bonds in (IV), and by two C—H…π hydrogen bonds in (IX). A single C—H…N hydrogen bond links the molecules of (X) into centrosymmetric dimers. Comparisons are made with the structures of some related compounds.     

The three‐dimensional hydrogen‐bonded framework structure in the 1:1 proton‐transfer compound of the drug quinacrine with 5‐sulfosalicylic acid

For the hydrated proton‐transfer compound 6‐chloro‐9‐[(4‐diethylammonio‐2‐methylbutyl)amino]‐2‐methoxyacridinium 3‐carboxylato‐4‐hydroxybenzenesulfonate dihydrate, C₂₃H₃₂ClN₃O²⁺·C₇H₄O₆S²⁻·2H₂O, (I), the conformational features, specifically those of the extended side chain at the 9‐position of the acridine parent, have been compared with those of quinacrinium dichloride dihydrate (the drug atabrine or mepacrine). Racemic compound (I) has a three‐dimensional hydrogen‐bonded framework structure similar to atabrine but also involves the water molecules and both the carboxylate and sulfonate groups of the anion in structure extension. The comparable conformational features found in this uncommon derivative of quinacrine indicate that (I) has potential as a possible pharmaceutical substitute for atabrine.     

Halogen,hydrogen and electrostatic interactions in 2‐amino‐5‐chloro‐1,3‐benzoxazol‐3‐ium nitrate and 2‐amino‐5‐chloro‐1,3‐benzoxazol‐3‐ium perchlorate

In the title compounds, C₇H₆ClN₂O⁺·NO₃⁻ and C₇H₆ClN₂O⁺·ClO₄⁻, the ions are connected by N—H...O hydrogen bonds and halogen interactions. Additionally, in the first compound, co‐operative π–π stacking and halogen...π interactions are observed. The energies of the observed interactions range from a value typical for very weak interactions (1.80 kJ mol⁻¹) to one typical for mildly strong interactions (53.01 kJ mol⁻¹). The iminium cations exist in an equilibrium form intermediate between exo‐ and endocyclic. This study provides structural insights relevant to the biochemical activity of 2‐amino‐5‐chloro‐1,3‐benzoxazole compounds.